We would like to invite you to attend the IPR Working Group election meeting on Patent Dispute on Novel Coronavirus Drug Remdeseviron 12th March, 14:00 – 16:00 via the digital platform Zoom (you will receive a link upon registration). This meeting will consist of three parts.
Firstly, this WG meeting will include the IPR Working Group 2020-2021 Chair elections. Only IPR WG members who had their registration confirmed for this meeting will have the right to vote online, with one vote per company. Online voting instructions will be sent via email to individual attendees prior to the meeting.
The second part of the WG meeting would be to discuss the Patent Issues with Novel Coronavirus Drug Remdesevir. At this meeting, Ms. Guo Songxi, Patent Counsel at Bayer China, will discuss the risks to IP Protection as it relates to the development of a drug to cure illness brought about by the novel coronavirus.
The third part of the Working Group meeting would be to brainstorm for the key recommendations for the 2020/2021 IPR position paper that will be drafted this coming half year (for the 2019/2020 IPR position paper click here).
Agenda
14:00 – 14:30
|
Registration & Networking
|
14:30 – 14:35
|
Opening Remarksby Mr. Paul Li, European Chamber IPR Working Group South China Vice Chair, General Manager at Ericsson
|
14:35 – 15:00
|
Chairs Elections and Online Voting
|
15:00 – 15:40
|
Presentation by Mr. Guo Songxi, Patent Counsel at Bayer China
|
15:40 – 16:00
|
Discussion of Key Recommendations for the IPR Position Paper moderated by Ms. Katie Feng, Vice Chair of European Chamber IPR Working Group, Partner at Hogan Lovells Shanghai
|
During this meeting we will hold our 2020-2021 chair elections. Working Group members interested in running for this year’s Chair elections, should take notice of the following:
Roles and Responsibilities
The Chairperson and Vice Chairs play a crucial role in driving the Working Group, including a leadership role in the drafting of the Position Paper, communicating key messages to Chinese and European government authorities and steering Working Group meetings. The desired characteristics of a Chair and Vice Chairs are a senior industry representative with relevant expertise and government contacts who has the time and willingness to support the Working Group. Previous participation in the Working Group is essential. Before applying for the position of Chair or Vice-chair, we recommend that you obtain approval from your company.
The maximum duration of Chairperson or Vice Chairperson of a Group is three consecutive years. Candidates are only eligible for Chair or Vice-Chair positions if he/she is physically based in China.
The IPR Working Group will elect one Chairperson and four Vice-Chairpersons (in the Beijing, Shanghai, and South China Chapters, respectively).
The Chairs and Vice-Chairs should represent different sectors and issues; therefore, we encourage employees across industries to apply for elections. If you are interested in the positions of Chair or Vice-Chair, please read the attached Starter Kit for Chairs and submit the following information to pdrucker@europeanchamber.com.cn or sthe@europeanchamber.com.cn before Friday 6th March, 10:00 am:
- Short resume/CV
- Motivation letter on why you wish to be elected Chair or Vice Chair, including:
- how your background and experience match the role
- the goals you have for the IPR working group over the following 12 months
- how you intend to utilise or share professional resources for the benefit of the Working Group
If you would like to attend this meeting, please click here or contact Ms. Sitong He at sthe@europeanchamber.com.cn or Mr. Peter Drucker at pdrucker@europeanchamber.com.cn for registration before 11th March, COB.
___________________________________________________________________________
For more information on the IPR Working Group or the European Chamber, please do not hesitate to contact Ms. Sitong He at sthe@europeanchamber.com.cn in Shanghai, and Mr. Peter Drucker at pdrucker@europeanchamber.com.cn in Guangzhou or visit our website.